MediciNova, Inc. (MNOV) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 186.98K | 151.74K | 123.32K | 134.6K | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 |
| Revenue Growth % | - | - | - | - | - | - | -100% | - | - | - | - | - |
| Cost of Goods Sold | 174.36K | 99.98K | 115.27K | 116.35K | 0 | 5.18K | 0 | 0 | 0 | 5.49K | 0 | 0 |
| COGS % of Revenue | 93.25% | 65.89% | 93.47% | 86.44% | - | - | - | - | - | - | - | - |
| Gross Profit | 12.62K | 51.76K | 8.05K | 18.25K | 0 | -5.18K | 0 | 0 | 0 | -5.49K | 1M | 0 |
| Gross Margin % | 6.75% | 34.11% | 6.53% | 13.56% | - | - | - | - | - | - | 100% | - |
| Gross Profit Growth % | - | 1099.77% | - | - | - | 5.74% | -100% | - | - | - | - | - |
| Operating Expenses | 2.85M | 3.14M | 3.39M | 3.63M | 3.2M | 3.18M | 3.31M | 3.05M | 3.14M | 2.48M | 2.15M | 3.3M |
| OpEx % of Revenue | 1523.35% | 2072.08% | 2748.19% | 2693.44% | - | - | - | - | - | - | 214.69% | - |
| Selling, General & Admin | 1.59B | 1.55M | 1.81M | 1.44M | 1.36M | 1.28M | 1.45M | 1.4M | 1.35M | 839.33K | 1.35M | 1.56M |
| SG&A % of Revenue | 850433.73% | 1023.95% | 1464.55% | 1067.39% | - | - | - | - | - | - | 135.22% | - |
| Research & Development | 1.26B | 1.69M | 1.58M | 2.19M | 1.74M | 1.91M | 1.77M | 1.54M | 1.64M | 1.65M | 701.71K | 1.64M |
| R&D % of Revenue | 675198.95% | 1114.03% | 1283.64% | 1626.05% | - | - | - | - | - | - | 70.17% | - |
| Other Operating Expenses | -1000K | -100K | 0 | 0 | 100K | -5.18K | 90K | 107K | 140K | 0 | 93K | 97K |
| Operating Income | -2.84M | -3.09M | -3.38M | -3.61M | -3.2M | -3.18M | -3.31M | -3.05M | -3.14M | -2.49M | -1.15M | -3.3M |
| Operating Margin % | -1516.6% | -2037.97% | -2741.67% | -2679.88% | - | - | - | - | - | - | -114.69% | - |
| Operating Income Growth % | 11.45% | 2.87% | -2.17% | -18.4% | -2.12% | -27.85% | -188.53% | 7.68% | -5.83% | 22.94% | 70.57% | 19.31% |
| EBITDA | -2.79M | -3.15M | -3.38M | -3.6M | -3.2M | -3.18M | -3.3M | -3.04M | -3.13M | -2.48M | -1.14M | -3.3M |
| EBITDA Margin % | -1492.64% | -2075.7% | -2737.37% | -2676.12% | - | - | - | - | - | - | -114.12% | - |
| EBITDA Growth % | 12.71% | 0.91% | -2.17% | -18.44% | -2.13% | -27.93% | -189.52% | 7.71% | -5.8% | 23% | 70.69% | 19.35% |
| D&A (Non-Cash Add-back) | 44.81K | -57.24K | 5.3K | 5.06K | 5.18K | 5.18K | 5.18K | 5.37K | 5.35K | 5.49K | 5.7K | 5K |
| EBIT | -2.84M | -2.8M | -3.38M | -3.61M | -3.2M | -3.18M | -3.31M | -3.05M | -3.14M | -2.06M | -1.15M | -3.3M |
| Net Interest Income | 252.96K | 340.21M | 340.85K | 324.95K | 336.11K | 390.1K | 447.85K | 435.35K | 397.51K | 436.26K | 437.93K | 451.42K |
| Interest Income | 252.96K | 340.21M | 340.85K | 324.95K | 336.11K | 390.1K | 447.85K | 435.35K | 397.51K | 436.26K | 437.93K | 451.42K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 249.55K | 296.12K | 330.63K | 325.91K | 338.39K | 374.6K | 456.95K | 418.3K | 381.48K | 434.07K | 423.78K | 428.21K |
| Pretax Income | -2.59M | -2.8M | -3.05M | -3.28M | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M | -723.11K | -2.87M |
| Pretax Margin % | -1383.14% | -1842.83% | -2473.56% | -2437.75% | - | - | - | - | - | - | -72.31% | - |
| Income Tax | 0 | 5.99K | 0 | 0 | 0 | 5.54K | 0 | 0 | 0 | 3.05K | 0 | 0 |
| Effective Tax Rate % | 0% | -0.21% | 0% | 0% | 0% | -0.2% | 0% | 0% | 0% | -0.15% | 0% | 0% |
| Net Income | -2.59M | -2.8M | -3.05M | -3.28M | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M | -723.11K | -2.87M |
| Net Margin % | -1383.14% | -1846.78% | -2473.56% | -2437.75% | - | - | - | - | - | - | -72.31% | - |
| Net Income Growth % | 9.7% | 0.44% | -6.95% | -24.85% | -3.98% | -36.69% | -294.43% | 8.48% | 5.59% | 31.4% | 80.2% | 28.72% |
| Net Income (Continuing) | -2.59M | -2.8M | -3.05M | -3.28M | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M | -723.11K | -2.87M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.05 | -0.05 | -0.06 | -0.07 | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 | -0.04 | -0.01 | -0.06 |
| EPS Growth % | 10.1% | 4.7% | -3.09% | -24.81% | -3.91% | -36.67% | -295.92% | 8.53% | 4.1% | 31.37% | 78.85% | 27.56% |
| EPS (Basic) | -0.05 | -0.05 | -0.06 | -0.07 | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 | -0.04 | -0.01 | -0.06 |
| Diluted Shares Outstanding | 49.22M | 49.06M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M |
| Basic Shares Outstanding | 49.22M | 49.06M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |